ESC 365 - Maturing hiPSC-cardiomyocytes in cardiac microtissues for accurate preclinical in vitro modelling of long-QT syndrome type 1

CBS PREMIUM ACCESS

Maturing hiPSC-cardiomyocytes in cardiac microtissues for accurate preclinical in vitro modelling of long-QT syndrome type 1

Session: Inherited arrhythmias: novel mechanisms and therapeutic targets

Topic: Arrhythmias

Speaker: Doctor G. Campostrini (Leiden, NL)

Event: Frontiers in CardioVascular Biomedicine 2024

Congress Presentation

Add to my library

About the speaker

Doctor Giulia Campostrini

Leiden University Medical Center, Leiden (Netherlands (The))

1 follower

4 more presentations in this session

Ventricular hyperinnervation in a mouse model of catecholaminergic polymorphic ventricular tachycardia

Speaker: Doctor M. O'Reilly (Amsterdam, NL)

SGK1 inhibition normalizes action potential duration in transgenic LQT2 rabbits but not in LQT1, suggesting a novel gene-specific therapeutic approach in long QT syndrome

Speaker: Miss M. Barbieri (Bern, CH)

Bradycardia in a long QT type 2 family: coinciding KCNH2 and HCN4 variants

Speaker: Ms J. Copier (Amsterdam, NL)

Interplay of electrical and mechanical properties in transgenic rabbit models of long-QT and short-QT syndrome

Speaker: Mr N. Alerni (Bern, CH)

Access the full session

Inherited arrhythmias: novel mechanisms and therapeutic targets

Speakers: Doctor G. Campostrini, Doctor M. O'Reilly, Miss M. Barbieri, Ms J. Copier, Mr N. Alerni

About the event

Frontiers in CardioVascular Biomedicine 2024

12 April - 14 April 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources